Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL

Daron Gale Ferris, Thomas C. Wright, Mark S. Litaker, Ralph M. Richart, Attila T. Lorincz, Xaio Wei Sun, Lisa Woodward

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

BACKGROUND. The detection of cancer-associated types of human papillomavirus (HPV) in cervical specimens predicts the presence and future development of cervical intraepithelial neoplasia (CIN). The purposes of this study were (1) to determine the efficacy of a second-generation assay by hybrid capture (HC II) to detect carcinogenic HPV from residual cervical cells of a liquid-based cervical cytologic specimen, and (2) to compare the performance of this second-generation test with the first-generation hybrid capture (HCT) HPV test of material from direct cervical sampling to detect CIN in women with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) Papanicolaou (Pap) smear reports. METHODS. Women with a recent Pap smear report of ASCUS or LSIL had a sampling of the cervix using either an Ayre's spatula and cytobrush or an Accellon device sampling for liquid-based cytologic system HC II HPV testing, followed by a Dacron swab sampling of the cervix for standard HCT HPV testing of the paired specimens. All women received colposcopy examinations including cervical biopsy and endocervical curettage, when indicated, to determine criterion standards for comparison. RESULTS. Paired swabs and liquid-based cervical specimens from 242 women were available for testing by standard HCT and the newer HC II HPV DNA assays. The sensitivity, specificity, and positive and negative predictive values for detecting CIN grade 2 or 3 (CIN 2/3) were 61.9%, 57.0%, 12.0%, and 94.0%, respectively, for the HCT test, and 90.5%, 29.4%, 10.9%, and 97.0%, respectively, for the liquid-based cytology HC II assay. When only women with an initial ASCUS Pap smear report were considered, the HC II test results were 88.9%, 40.3%, 9.1%, and 98.2%, respectively. CONCLUSIONS. Testing for lower genital tract carcinogenic HPV DNA using a cervical cytology liquid transport media residual sample is clinically feasible. The new HC II microplate HPV test achieved a greater test sensitivity for detecting carcinogenic HPV and correspondingly of CIN 2/3 compared with currently available first-generation HC HPV test. Use of a liquid-based cervical cytology system combined with intermediate triage by HC II testing of residual cells for carcinogenic HPV alone may help to efficiently identify CIN 2/3 in women who have a prior screening Pap smear report of ASCUS.

Original languageEnglish (US)
Pages (from-to)136-141
Number of pages6
JournalJournal of Family Practice
Volume46
Issue number2
StatePublished - Feb 1 1998

Fingerprint

Papanicolaou Test
Cervical Intraepithelial Neoplasia
Cell Biology
Cervix Uteri
Squamous Intraepithelial Lesions of the Cervix
Atypical Squamous Cells of the Cervix
Colposcopy
Polyethylene Terephthalates
Curettage
Triage
DNA

Keywords

  • Cervical dysplasia
  • Colposcopy
  • DNA probes
  • HPV
  • Papanicolaou

ASJC Scopus subject areas

  • Family Practice

Cite this

Ferris, D. G., Wright, T. C., Litaker, M. S., Richart, R. M., Lorincz, A. T., Sun, X. W., & Woodward, L. (1998). Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL. Journal of Family Practice, 46(2), 136-141.

Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL. / Ferris, Daron Gale; Wright, Thomas C.; Litaker, Mark S.; Richart, Ralph M.; Lorincz, Attila T.; Sun, Xaio Wei; Woodward, Lisa.

In: Journal of Family Practice, Vol. 46, No. 2, 01.02.1998, p. 136-141.

Research output: Contribution to journalArticle

Ferris, DG, Wright, TC, Litaker, MS, Richart, RM, Lorincz, AT, Sun, XW & Woodward, L 1998, 'Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL', Journal of Family Practice, vol. 46, no. 2, pp. 136-141.
Ferris, Daron Gale ; Wright, Thomas C. ; Litaker, Mark S. ; Richart, Ralph M. ; Lorincz, Attila T. ; Sun, Xaio Wei ; Woodward, Lisa. / Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL. In: Journal of Family Practice. 1998 ; Vol. 46, No. 2. pp. 136-141.
@article{67f068a067a74a41b5c1b8f4af35b8b2,
title = "Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL",
abstract = "BACKGROUND. The detection of cancer-associated types of human papillomavirus (HPV) in cervical specimens predicts the presence and future development of cervical intraepithelial neoplasia (CIN). The purposes of this study were (1) to determine the efficacy of a second-generation assay by hybrid capture (HC II) to detect carcinogenic HPV from residual cervical cells of a liquid-based cervical cytologic specimen, and (2) to compare the performance of this second-generation test with the first-generation hybrid capture (HCT) HPV test of material from direct cervical sampling to detect CIN in women with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) Papanicolaou (Pap) smear reports. METHODS. Women with a recent Pap smear report of ASCUS or LSIL had a sampling of the cervix using either an Ayre's spatula and cytobrush or an Accellon device sampling for liquid-based cytologic system HC II HPV testing, followed by a Dacron swab sampling of the cervix for standard HCT HPV testing of the paired specimens. All women received colposcopy examinations including cervical biopsy and endocervical curettage, when indicated, to determine criterion standards for comparison. RESULTS. Paired swabs and liquid-based cervical specimens from 242 women were available for testing by standard HCT and the newer HC II HPV DNA assays. The sensitivity, specificity, and positive and negative predictive values for detecting CIN grade 2 or 3 (CIN 2/3) were 61.9{\%}, 57.0{\%}, 12.0{\%}, and 94.0{\%}, respectively, for the HCT test, and 90.5{\%}, 29.4{\%}, 10.9{\%}, and 97.0{\%}, respectively, for the liquid-based cytology HC II assay. When only women with an initial ASCUS Pap smear report were considered, the HC II test results were 88.9{\%}, 40.3{\%}, 9.1{\%}, and 98.2{\%}, respectively. CONCLUSIONS. Testing for lower genital tract carcinogenic HPV DNA using a cervical cytology liquid transport media residual sample is clinically feasible. The new HC II microplate HPV test achieved a greater test sensitivity for detecting carcinogenic HPV and correspondingly of CIN 2/3 compared with currently available first-generation HC HPV test. Use of a liquid-based cervical cytology system combined with intermediate triage by HC II testing of residual cells for carcinogenic HPV alone may help to efficiently identify CIN 2/3 in women who have a prior screening Pap smear report of ASCUS.",
keywords = "Cervical dysplasia, Colposcopy, DNA probes, HPV, Papanicolaou",
author = "Ferris, {Daron Gale} and Wright, {Thomas C.} and Litaker, {Mark S.} and Richart, {Ralph M.} and Lorincz, {Attila T.} and Sun, {Xaio Wei} and Lisa Woodward",
year = "1998",
month = "2",
day = "1",
language = "English (US)",
volume = "46",
pages = "136--141",
journal = "Journal of Family Practice",
issn = "0094-3509",
publisher = "Appleton-Century-Crofts",
number = "2",

}

TY - JOUR

T1 - Comparison of two tests for detecting carcinogenic HPV in women with papanicolaou smear reports of ASCUS and LSIL

AU - Ferris, Daron Gale

AU - Wright, Thomas C.

AU - Litaker, Mark S.

AU - Richart, Ralph M.

AU - Lorincz, Attila T.

AU - Sun, Xaio Wei

AU - Woodward, Lisa

PY - 1998/2/1

Y1 - 1998/2/1

N2 - BACKGROUND. The detection of cancer-associated types of human papillomavirus (HPV) in cervical specimens predicts the presence and future development of cervical intraepithelial neoplasia (CIN). The purposes of this study were (1) to determine the efficacy of a second-generation assay by hybrid capture (HC II) to detect carcinogenic HPV from residual cervical cells of a liquid-based cervical cytologic specimen, and (2) to compare the performance of this second-generation test with the first-generation hybrid capture (HCT) HPV test of material from direct cervical sampling to detect CIN in women with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) Papanicolaou (Pap) smear reports. METHODS. Women with a recent Pap smear report of ASCUS or LSIL had a sampling of the cervix using either an Ayre's spatula and cytobrush or an Accellon device sampling for liquid-based cytologic system HC II HPV testing, followed by a Dacron swab sampling of the cervix for standard HCT HPV testing of the paired specimens. All women received colposcopy examinations including cervical biopsy and endocervical curettage, when indicated, to determine criterion standards for comparison. RESULTS. Paired swabs and liquid-based cervical specimens from 242 women were available for testing by standard HCT and the newer HC II HPV DNA assays. The sensitivity, specificity, and positive and negative predictive values for detecting CIN grade 2 or 3 (CIN 2/3) were 61.9%, 57.0%, 12.0%, and 94.0%, respectively, for the HCT test, and 90.5%, 29.4%, 10.9%, and 97.0%, respectively, for the liquid-based cytology HC II assay. When only women with an initial ASCUS Pap smear report were considered, the HC II test results were 88.9%, 40.3%, 9.1%, and 98.2%, respectively. CONCLUSIONS. Testing for lower genital tract carcinogenic HPV DNA using a cervical cytology liquid transport media residual sample is clinically feasible. The new HC II microplate HPV test achieved a greater test sensitivity for detecting carcinogenic HPV and correspondingly of CIN 2/3 compared with currently available first-generation HC HPV test. Use of a liquid-based cervical cytology system combined with intermediate triage by HC II testing of residual cells for carcinogenic HPV alone may help to efficiently identify CIN 2/3 in women who have a prior screening Pap smear report of ASCUS.

AB - BACKGROUND. The detection of cancer-associated types of human papillomavirus (HPV) in cervical specimens predicts the presence and future development of cervical intraepithelial neoplasia (CIN). The purposes of this study were (1) to determine the efficacy of a second-generation assay by hybrid capture (HC II) to detect carcinogenic HPV from residual cervical cells of a liquid-based cervical cytologic specimen, and (2) to compare the performance of this second-generation test with the first-generation hybrid capture (HCT) HPV test of material from direct cervical sampling to detect CIN in women with atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) Papanicolaou (Pap) smear reports. METHODS. Women with a recent Pap smear report of ASCUS or LSIL had a sampling of the cervix using either an Ayre's spatula and cytobrush or an Accellon device sampling for liquid-based cytologic system HC II HPV testing, followed by a Dacron swab sampling of the cervix for standard HCT HPV testing of the paired specimens. All women received colposcopy examinations including cervical biopsy and endocervical curettage, when indicated, to determine criterion standards for comparison. RESULTS. Paired swabs and liquid-based cervical specimens from 242 women were available for testing by standard HCT and the newer HC II HPV DNA assays. The sensitivity, specificity, and positive and negative predictive values for detecting CIN grade 2 or 3 (CIN 2/3) were 61.9%, 57.0%, 12.0%, and 94.0%, respectively, for the HCT test, and 90.5%, 29.4%, 10.9%, and 97.0%, respectively, for the liquid-based cytology HC II assay. When only women with an initial ASCUS Pap smear report were considered, the HC II test results were 88.9%, 40.3%, 9.1%, and 98.2%, respectively. CONCLUSIONS. Testing for lower genital tract carcinogenic HPV DNA using a cervical cytology liquid transport media residual sample is clinically feasible. The new HC II microplate HPV test achieved a greater test sensitivity for detecting carcinogenic HPV and correspondingly of CIN 2/3 compared with currently available first-generation HC HPV test. Use of a liquid-based cervical cytology system combined with intermediate triage by HC II testing of residual cells for carcinogenic HPV alone may help to efficiently identify CIN 2/3 in women who have a prior screening Pap smear report of ASCUS.

KW - Cervical dysplasia

KW - Colposcopy

KW - DNA probes

KW - HPV

KW - Papanicolaou

UR - http://www.scopus.com/inward/record.url?scp=0031914561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031914561&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 136

EP - 141

JO - Journal of Family Practice

JF - Journal of Family Practice

SN - 0094-3509

IS - 2

ER -